WithdrawnNCT02432066
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
Medication studyAges 25–60Addiction
Understand this study
Who could participate?
Listed age limits: 25 years to 60 years.
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 29, 2018
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of Florida
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Not clearly listed
- Age range
- From 25 Years to 60 Years
- Official registry ID
- NCT02432066
- Official title
Show the full official title
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Florida, a university.
Does this study involve medication?
Yes. The study involves medication, including GTS-21 and Placebo.
Who can participate?
Listed age limits: 25 years to 60 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
